Opthea Announces Publication in Diabetic Macular Edema
Phase 1b clinical data underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to improve visual and anatomic outcomes in ...
ONL Therapeutics Appoints Penny Fleck as Chief Development Officer
In September, ONL announced the closing of a $65 million Series D financing round, led by Johnson & Johnson Innovation – JJDC, Inc. The Series D funding supports the advancement of the development of ...
Microsoft to invest $3 billion in India, to expand AI and cloud capacity
Microsoft will spend $3 billion to expand its Azure cloud and artificial intelligence (AI) capacity in India, CEO Satya ...